e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Looking backwards: is it time to assess veno-atrial interactions in pulmonary arterial hypertension?
Steven Pugliese, Rebecca R. Vanderpool
Source:
Eur Respir J, 54 (4) 1901598; 10.1183/13993003.01598-2019
Journal Issue:
October
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Steven Pugliese, Rebecca R. Vanderpool. Looking backwards: is it time to assess veno-atrial interactions in pulmonary arterial hypertension?. Eur Respir J, 54 (4) 1901598; 10.1183/13993003.01598-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Predicting survival in pulmonary arterial hypertension: time to move forward
Source: Eur Respir J 2010; 35: 958-959
Year: 2010
End points for pulmonary arterial hypertension: a way backward
Source: Eur Respir J 2004; 24 : 890-891
Year: 2004
Inflammation in pulmonary arterial hypertension: is it time to quell the fire?
Source: Eur Respir J 2014; 43: 685-688
Year: 2014
Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against
Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018
Year: 2018
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm
Source: Eur Respir J 2015; 46: 299-302
Year: 2015
Pulmonary arterial hypertension and CFTR: the paradox of going forward by tacking sideways!
Source: Eur Respir J, 58 (5) 2101839; 10.1183/13993003.01839-2021
Year: 2021
Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better?
Source: Eur Respir J 2006 Oct 01;28(4):683-686
Year: 2006
Pulmonary arterial hypertension: bridging the present to the future
Source: Eur Respir Rev 2012 21: 267-270
Year: 2012
Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how?
Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases
Year: 2020
Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?
Source: Eur Respir J, 51 (2) 1702589; 10.1183/13993003.02589-2017
Year: 2018
Parasympathetic activity in pulmonary arterial hypertension: could a simple measure do the trick?
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Source: Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020
Year: 2020
Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction?
Source: Eur Respir Rev 2009; 19: 4-6
Year: 2010
End points in pulmonary arterial hypertension: the way forward
Source: Eur Respir J 2004; 23: 947-953
Year: 2004
“Rehab for all!” Is it too early in pulmonary arterial hypertension?
Source: Eur Respir J, 54 (5) 1901558; 10.1183/13993003.01558-2019
Year: 2019
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
Source: Eur Respir J 2014; 44: 1404-1407
Year: 2014
Measuring health in pulmonary hypertension: emphasising the right end-point?
Source: Eur Respir J 2014; 43: 960-962
Year: 2014
Clinical trials in pulmonary arterial hypertension: what do they tell us
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
Clinical trials in pulmonary arterial hypertension: what they tell us
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Clinical trials in pulmonary arterial hypertension: what do they tell us
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept